<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101461858</journal-id>
<journal-id journal-id-type="pubmed-jr-id">35583</journal-id>
<journal-id journal-id-type="nlm-ta">Autism Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Autism Res</journal-id>
<journal-title-group>
<journal-title>Autism research : official journal of the International Society for Autism Research</journal-title>
</journal-title-group>
<issn pub-type="ppub">1939-3792</issn>
<issn pub-type="epub">1939-3806</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29573234</article-id>
<article-id pub-id-type="pmc">6188783</article-id>
<article-id pub-id-type="doi">10.1002/aur.1945</article-id>
<article-id pub-id-type="manuscript">NIHMS963333</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Modeling Autism in Non-Human Primates: Opportunities and Challenges</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Hui</given-names>
</name>
<aff id="A1">State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China</aff>
<aff id="A2">University of Chinese Academy of Sciences, Beijing, China</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Yong-Hui</given-names>
</name>
<aff id="A3">Department of Pediatrics and Department of Neurobiology, Duke University, Durham, North Carolina 27710</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yong Q.</given-names>
</name>
<aff id="A4">State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing, China</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="FN1">Address for correspondence and reprints: Yong Q. Zhang, State Key Laboratory of Molecular Developmental Biology, Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China. <email>yqzhang@genetics.ac.cn</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>30</day>
<month>4</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>15</day>
<month>10</month>
<year>2018</year>
</pub-date>
<volume>11</volume>
<issue>5</issue>
<fpage>686</fpage>
<lpage>694</lpage>
<!--elocation-id from pubmed: 10.1002/aur.1945-->
<abstract>
<p id="P1">Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by social communication deficits and restricted, repetitive patterns of behavior. For more than a decade, genetically-modified, risk factor-induced, as well as naturally occurring rodent models for ASD have been used as the most predominant tools to dissect the molecular and circuitry mechanisms underlying ASD. However, the apparent evolutionary differences in terms of social behavior and brain anatomy between rodents and humans have become an issue of debate regarding the translational value of rodent models for studying ASD. More recently, genome manipulation of non human primates using lentivirus-based gene expression, TALEN and CRISPR/Cas9 mediated gene editing techniques, has been reported. Genetically modified non-human primate models for ASD have been produced and characterized. While the feasibility, value, and exciting opportunities provided by the non-human primate models have been clearly demonstrated, many challenges still remain. Here, we review current progress, discuss the remaining challenges, and highlight the key issues in the development of non-human primate models for ASD research and drug development.</p>
</abstract>
<kwd-group>
<kwd>non-human primate</kwd>
<kwd>autism</kwd>
<kwd>social behavior</kwd>
<kwd>CRISPR/Cas9</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>